Table 2.

Clinical and anthropometrics characteristics in study subjects according to IGF1 (rs35767) genotypes

	GG (n = 191)	AG (n = 72)	AA (n = 15)	p value
Age	14.40 ± 3.02	14.64 ± 3.06	15.50 ± 1.96	0.362
Males, n (%)	102 (53.4)	34 (47.2)	10 (66.7)	0.355
Years of diabetes	7.41 ± 3.67	7.60 ± 3.48	9.10 ± 2.73	0.210
Body height (cm)	160.4 ± 13.8	161.7 ± 14.1	167.6 ± 11.2	0.140
Body weight (kg)	55.82 ± 15.89	57.17 ± 15.89	61.00 ± 11.90	0.425
BMI	21.22 ± 3.65	21.40 ± 3.42	21.57 ± 3.09	0.888
BMI z-score	0.39 ± 0.87	0.47 ± 0.97	0.30 ± 0.83	0.947
SBP (mmHg)	107.6 ± 11.0	107.7 ± 10.4	106.8 ± 9.0	0.960
SBP percentile	36.4 [17.8–61.2]	32.8 [18.8–56.5]	33.0 [2.8–56.4]	0.608
DBP (mmHg)	68.0 ± 7.9	68.5 ± 5.7	70.5 ± 7.3	0.416
DBP percentile	61.8 [44.4–77.8]	58.6 [45.0–75.4]	68.0 [45.6–78.8]	0.728
HbA1c (%)	8.0 [7.4–8.5]	7.9 [7.3–8.5]	8.1 [7.5–8.4]	0.702
Serum creatinine (mg/dL)	0.63 ± 0.15	0.65 ± 0.15	0.73 ± 0.10	0.033
eGFR (mL/min)	109.8 ± 20.8	106.3 ± 18.9	96.7 ± 12.9	0.033
ACR (mg/mmol)	0.35 [0.20–0.67]	0.38 [0.20–0.80]	0.59 [0.24–1.22]	0.332

Data are expressed as means ± SD, medians [IQR]. Differences among groups were tested by ANOVA for normally distributed continuous variables, and the Kruskal–Wallis’s test for skewed variables

In bold statistically significant differencies are reported

BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, ACR albumin-to-creatinine ratio